Stock Markets April 27, 2026 07:39 AM

U.S. Futures Mixed Ahead of Heavy Week; Verizon, Qualcomm Gain While GE Vernova Falls

Markets eye geopolitical risks and AI-capex week as select telecom and chip names move in early trading

By Avery Klein ADBE
U.S. Futures Mixed Ahead of Heavy Week; Verizon, Qualcomm Gain While GE Vernova Falls
ADBE

U.S. stock futures showed mixed action Monday morning as traders readied for a congested week of events ranging from geopolitical developments to earnings from large AI-focused cloud providers. By 06:46 ET (10:46 GMT), Dow futures were down 39 points (-0.1%), the S&P 500 was essentially flat, and Nasdaq 100 futures were up 37 points (0.1%). Several individual stocks registered notable premarket moves after earnings guidance changes, analyst downgrades and clinical-trial updates.

Key Points

  • U.S. futures were mixed early Monday with the Dow down 39 points (-0.1%), S&P 500 largely flat, and Nasdaq 100 up 37 points (0.1%) at 06:46 ET (10:46 GMT).
  • Verizon raised its annual profit forecast and reported unexpected first-quarter wireless subscriber additions, boosting its shares.
  • Qualcomm jumped after reports from TF International Securities indicated potential collaboration with OpenAI and MediaTek on smartphone semiconductors; GE Vernova was downgraded by BNP Paribas.

U.S. equity futures displayed divergent moves in early Monday trade as market participants braced for a busy calendar that includes geopolitical headlines and earnings from major artificial intelligence hyperscalers.

By 06:46 ET (10:46 GMT), the Dow futures contract had slipped by 39 points, or 0.1%. The S&P 500 was mostly flat, while Nasdaq 100 futures had climbed 37 points, or 0.1%.


Several companies stood out among premarket movers:

  • Verizon - Shares rose after the telecommunications company raised its full-year profit outlook. Verizon also recorded unexpected wireless subscriber gains in the first quarter, an outcome management attributed in part to bundled plans and revamped promotions.
  • GE Vernova - The power equipment unit slid after BNP Paribas analysts downgraded the business from "buy" to "neutral," pointing to concerns about the firm's future growth momentum.
  • Qualcomm - The chipmaker jumped following comments from TF International Securities analysts who said industry checks suggested Qualcomm is collaborating with OpenAI and Taiwan's MediaTek on smartphone semiconductors.
  • Adobe - Shares moved lower after Mizuho cut its rating to "neutral" from "outperform" and trimmed its price target, flagging worries over the ability of the company's AI-first annual recurring revenue to "bend the growth curve anytime soon."
  • Intellia Therapeutics - Stock action was choppy after the company reported that an experimental therapy for a rare disorder that causes swelling in parts of the body met the primary endpoint in a late-stage trial.
  • Oruka Therapeutics - The biotech surged after announcing its experimental injectable psoriasis treatment met the primary goal in a mid-stage clinical study.

These premarket moves reflect a mix of corporate guidance revisions, analyst scorecard changes and clinical-trial readouts. Telecom and semiconductor sectors were among those directly affected by the morning headlines, while parts of the healthcare and industrial equipment complex also saw early reactions.

The market will be watching incoming corporate reports and broader geopolitical developments closely through the trading week as investors assess implications for demand, pricing and growth momentum across sectors.

Separately, readers were signaled to tools that evaluate stock valuations, with a prompt regarding Adobe's valuation using a Fair Value calculator that aggregates multiple industry models.

Risks

  • Analyst downgrades and lowered price targets can pressure stock prices in sectors such as industrial equipment and software, as seen with GE Vernova and Adobe.
  • Clinical-trial results create volatility for biotechnology names; while positive readouts lift shares (Oruka, Intellia), future trial outcomes remain a source of uncertainty for healthcare sector investors.

More from Stock Markets

Northland Lowers AMD Rating to Market Perform After 11 Years of Bullish Coverage Apr 27, 2026 Greenland Energy Stock Surges After Halliburton Agreement for Jameson Land Campaign Apr 27, 2026 Critical Metals to Acquire European Lithium in Stock Exchange Deal Worth About $835 Million Apr 27, 2026 Customers Bank Engages OpenAI Engineers to Automate Lending and Onboarding Apr 27, 2026 Compass Therapeutics Shares Collapse After Mixed COMPANION-002 Results Apr 27, 2026